Oncolytic Adenovirus(H101) Combined With PD-1 Inhibitors in Patients With Advanced Malignant Pleural Mesothelioma

NCT06031636 · clinicaltrials.gov ↗

RECRUITING

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Malignant Pleural Mesothelioma, Advanced

Interventions

DRUG: Oncolytic Adenovirus H101
DRUG: Programmed death receptor-1 inhibitor

Sponsor

Tianjin Medical University Second Hospital